Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Sell
22
DTIL Quote, Financials, Valuation and Earnings
Last price:
$5.01
Seasonality move
:
-18.41%
Day range:
$4.89 - $5.19
52-week range:
$3.61 - $8.82
Dividend yield:
0%
P/E ratio:
3.41x
P/S ratio:
72.20x
P/B ratio:
4.00x
Volume:
194.9K
Avg. volume:
224.5K
1-year change:
-18.77%
Market cap:
$66.5M
Revenue:
$68.7M
EPS (TTM):
-$8.40
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
DTIL
Precision BioSciences, Inc.
|
$5.4M | -$2.21 | 1322.41% | -67.39% | $32.50 |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$3M | -$0.88 | 14.03% | -95.43% | $0.85 |
|
NNVC
NanoViricides, Inc.
|
-- | -$0.20 | -- | -26.67% | $7.00 |
|
OGEN
Oragenics, Inc.
|
-- | -- | -- | -- | $2.00 |
|
PTN
Palatin Technologies
|
-- | -$0.17 | -- | -67.93% | -- |
|
TOVX
Theriva Biologics, Inc.
|
-- | -$0.38 | -- | -94.42% | $7.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
DTIL
Precision BioSciences, Inc.
|
$5.02 | $32.50 | $66.5M | 3.41x | $0.00 | 0% | 72.20x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$1.09 | $0.85 | $137.4M | 1.83x | $0.80 | 0% | 2.12x |
|
NNVC
NanoViricides, Inc.
|
$1.22 | $7.00 | $22M | -- | $0.00 | 0% | -- |
|
OGEN
Oragenics, Inc.
|
$0.85 | $2.00 | $700.8K | -- | $0.00 | 0% | 0.53x |
|
PTN
Palatin Technologies
|
$0.09 | -- | $2.4M | -- | $0.00 | 0% | -- |
|
TOVX
Theriva Biologics, Inc.
|
$0.24 | $7.00 | $8.2M | -- | $0.00 | 0% | 0.33x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
DTIL
Precision BioSciences, Inc.
|
63.65% | 2.082 | 43.67% | 2.99x |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
37.25% | 2.113 | 8.08% | 1.85x |
|
NNVC
NanoViricides, Inc.
|
-- | 0.464 | -- | 0.95x |
|
OGEN
Oragenics, Inc.
|
3.86% | -0.075 | 36.62% | 3.97x |
|
PTN
Palatin Technologies
|
-- | 1.358 | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
29.07% | -3.365 | 66.16% | 0.68x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
DTIL
Precision BioSciences, Inc.
|
-$661K | -$20.7M | -112.99% | -188.9% | -158976.92% | -$15.3M |
|
NBY
NovaBay Pharmaceuticals, Inc.
|
$42K | -$1.2M | -208.55% | -306.03% | -224.38% | -$1.8M |
|
NNVC
NanoViricides, Inc.
|
-$132.8K | -$1.8M | -92.29% | -92.29% | -- | -$1.7M |
|
OGEN
Oragenics, Inc.
|
-- | -$3.1M | -311.49% | -509.23% | -- | -$3M |
|
PTN
Palatin Technologies
|
-- | -- | -- | -- | -- | -- |
|
TOVX
Theriva Biologics, Inc.
|
-$28K | -$4.4M | -148.18% | -171.04% | -- | -$4.3M |
Precision BioSciences, Inc. vs. Competitors
-
Which has Higher Returns DTIL or NBY?
NovaBay Pharmaceuticals, Inc. has a net margin of -167476.92% compared to Precision BioSciences, Inc.'s net margin of -255.85%. Precision BioSciences, Inc.'s return on equity of -188.9% beat NovaBay Pharmaceuticals, Inc.'s return on equity of -306.03%.
Company Gross Margin Earnings Per Share Invested Capital DTILPrecision BioSciences, Inc.-5084.62% -$1.84 $45.8M NBYNovaBay Pharmaceuticals, Inc.8.06% -$0.22 $2.6M -
What do Analysts Say About DTIL or NBY?
Precision BioSciences, Inc. has a consensus price target of $32.50, signalling upside risk potential of 547.41%. On the other hand NovaBay Pharmaceuticals, Inc. has an analysts' consensus of $0.85 which suggests that it could fall by -22.02%. Given that Precision BioSciences, Inc. has higher upside potential than NovaBay Pharmaceuticals, Inc., analysts believe Precision BioSciences, Inc. is more attractive than NovaBay Pharmaceuticals, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DTILPrecision BioSciences, Inc.4 0 0 NBYNovaBay Pharmaceuticals, Inc.1 0 0 -
Is DTIL or NBY More Risky?
Precision BioSciences, Inc. has a beta of 1.110, which suggesting that the stock is 10.998% more volatile than S&P 500. In comparison NovaBay Pharmaceuticals, Inc. has a beta of 0.569, suggesting its less volatile than the S&P 500 by 43.103%.
-
Which is a Better Dividend Stock DTIL or NBY?
Precision BioSciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NovaBay Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.80 per share. Precision BioSciences, Inc. pays -- of its earnings as a dividend. NovaBay Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DTIL or NBY?
Precision BioSciences, Inc. quarterly revenues are $13K, which are smaller than NovaBay Pharmaceuticals, Inc. quarterly revenues of $521K. Precision BioSciences, Inc.'s net income of -$21.8M is lower than NovaBay Pharmaceuticals, Inc.'s net income of -$1.3M. Notably, Precision BioSciences, Inc.'s price-to-earnings ratio is 3.41x while NovaBay Pharmaceuticals, Inc.'s PE ratio is 1.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision BioSciences, Inc. is 72.20x versus 2.12x for NovaBay Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DTILPrecision BioSciences, Inc.72.20x 3.41x $13K -$21.8M NBYNovaBay Pharmaceuticals, Inc.2.12x 1.83x $521K -$1.3M
-
Which has Higher Returns DTIL or NNVC?
NanoViricides, Inc. has a net margin of -167476.92% compared to Precision BioSciences, Inc.'s net margin of --. Precision BioSciences, Inc.'s return on equity of -188.9% beat NanoViricides, Inc.'s return on equity of -92.29%.
Company Gross Margin Earnings Per Share Invested Capital DTILPrecision BioSciences, Inc.-5084.62% -$1.84 $45.8M NNVCNanoViricides, Inc.-- -$0.10 $7.2M -
What do Analysts Say About DTIL or NNVC?
Precision BioSciences, Inc. has a consensus price target of $32.50, signalling upside risk potential of 547.41%. On the other hand NanoViricides, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 473.77%. Given that Precision BioSciences, Inc. has higher upside potential than NanoViricides, Inc., analysts believe Precision BioSciences, Inc. is more attractive than NanoViricides, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DTILPrecision BioSciences, Inc.4 0 0 NNVCNanoViricides, Inc.0 0 0 -
Is DTIL or NNVC More Risky?
Precision BioSciences, Inc. has a beta of 1.110, which suggesting that the stock is 10.998% more volatile than S&P 500. In comparison NanoViricides, Inc. has a beta of 1.158, suggesting its more volatile than the S&P 500 by 15.816%.
-
Which is a Better Dividend Stock DTIL or NNVC?
Precision BioSciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoViricides, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision BioSciences, Inc. pays -- of its earnings as a dividend. NanoViricides, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DTIL or NNVC?
Precision BioSciences, Inc. quarterly revenues are $13K, which are larger than NanoViricides, Inc. quarterly revenues of --. Precision BioSciences, Inc.'s net income of -$21.8M is lower than NanoViricides, Inc.'s net income of -$1.8M. Notably, Precision BioSciences, Inc.'s price-to-earnings ratio is 3.41x while NanoViricides, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision BioSciences, Inc. is 72.20x versus -- for NanoViricides, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DTILPrecision BioSciences, Inc.72.20x 3.41x $13K -$21.8M NNVCNanoViricides, Inc.-- -- -- -$1.8M
-
Which has Higher Returns DTIL or OGEN?
Oragenics, Inc. has a net margin of -167476.92% compared to Precision BioSciences, Inc.'s net margin of --. Precision BioSciences, Inc.'s return on equity of -188.9% beat Oragenics, Inc.'s return on equity of -509.23%.
Company Gross Margin Earnings Per Share Invested Capital DTILPrecision BioSciences, Inc.-5084.62% -$1.84 $45.8M OGENOragenics, Inc.-- -$1.96 $10.2M -
What do Analysts Say About DTIL or OGEN?
Precision BioSciences, Inc. has a consensus price target of $32.50, signalling upside risk potential of 547.41%. On the other hand Oragenics, Inc. has an analysts' consensus of $2.00 which suggests that it could grow by 134.85%. Given that Precision BioSciences, Inc. has higher upside potential than Oragenics, Inc., analysts believe Precision BioSciences, Inc. is more attractive than Oragenics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DTILPrecision BioSciences, Inc.4 0 0 OGENOragenics, Inc.1 0 0 -
Is DTIL or OGEN More Risky?
Precision BioSciences, Inc. has a beta of 1.110, which suggesting that the stock is 10.998% more volatile than S&P 500. In comparison Oragenics, Inc. has a beta of 0.922, suggesting its less volatile than the S&P 500 by 7.781%.
-
Which is a Better Dividend Stock DTIL or OGEN?
Precision BioSciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oragenics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision BioSciences, Inc. pays -- of its earnings as a dividend. Oragenics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DTIL or OGEN?
Precision BioSciences, Inc. quarterly revenues are $13K, which are larger than Oragenics, Inc. quarterly revenues of --. Precision BioSciences, Inc.'s net income of -$21.8M is lower than Oragenics, Inc.'s net income of -$3.1M. Notably, Precision BioSciences, Inc.'s price-to-earnings ratio is 3.41x while Oragenics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision BioSciences, Inc. is 72.20x versus 0.53x for Oragenics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DTILPrecision BioSciences, Inc.72.20x 3.41x $13K -$21.8M OGENOragenics, Inc.0.53x -- -- -$3.1M
-
Which has Higher Returns DTIL or PTN?
Palatin Technologies has a net margin of -167476.92% compared to Precision BioSciences, Inc.'s net margin of --. Precision BioSciences, Inc.'s return on equity of -188.9% beat Palatin Technologies's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital DTILPrecision BioSciences, Inc.-5084.62% -$1.84 $45.8M PTNPalatin Technologies-- -- -- -
What do Analysts Say About DTIL or PTN?
Precision BioSciences, Inc. has a consensus price target of $32.50, signalling upside risk potential of 547.41%. On the other hand Palatin Technologies has an analysts' consensus of -- which suggests that it could grow by 7338.9%. Given that Palatin Technologies has higher upside potential than Precision BioSciences, Inc., analysts believe Palatin Technologies is more attractive than Precision BioSciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DTILPrecision BioSciences, Inc.4 0 0 PTNPalatin Technologies0 0 0 -
Is DTIL or PTN More Risky?
Precision BioSciences, Inc. has a beta of 1.110, which suggesting that the stock is 10.998% more volatile than S&P 500. In comparison Palatin Technologies has a beta of 0.939, suggesting its less volatile than the S&P 500 by 6.103%.
-
Which is a Better Dividend Stock DTIL or PTN?
Precision BioSciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Palatin Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision BioSciences, Inc. pays -- of its earnings as a dividend. Palatin Technologies pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DTIL or PTN?
Precision BioSciences, Inc. quarterly revenues are $13K, which are larger than Palatin Technologies quarterly revenues of --. Precision BioSciences, Inc.'s net income of -$21.8M is higher than Palatin Technologies's net income of --. Notably, Precision BioSciences, Inc.'s price-to-earnings ratio is 3.41x while Palatin Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision BioSciences, Inc. is 72.20x versus -- for Palatin Technologies. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DTILPrecision BioSciences, Inc.72.20x 3.41x $13K -$21.8M PTNPalatin Technologies-- -- -- --
-
Which has Higher Returns DTIL or TOVX?
Theriva Biologics, Inc. has a net margin of -167476.92% compared to Precision BioSciences, Inc.'s net margin of --. Precision BioSciences, Inc.'s return on equity of -188.9% beat Theriva Biologics, Inc.'s return on equity of -171.04%.
Company Gross Margin Earnings Per Share Invested Capital DTILPrecision BioSciences, Inc.-5084.62% -$1.84 $45.8M TOVXTheriva Biologics, Inc.-- -$0.45 $9.5M -
What do Analysts Say About DTIL or TOVX?
Precision BioSciences, Inc. has a consensus price target of $32.50, signalling upside risk potential of 547.41%. On the other hand Theriva Biologics, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 2797.35%. Given that Theriva Biologics, Inc. has higher upside potential than Precision BioSciences, Inc., analysts believe Theriva Biologics, Inc. is more attractive than Precision BioSciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings DTILPrecision BioSciences, Inc.4 0 0 TOVXTheriva Biologics, Inc.1 1 0 -
Is DTIL or TOVX More Risky?
Precision BioSciences, Inc. has a beta of 1.110, which suggesting that the stock is 10.998% more volatile than S&P 500. In comparison Theriva Biologics, Inc. has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.818%.
-
Which is a Better Dividend Stock DTIL or TOVX?
Precision BioSciences, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Theriva Biologics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Precision BioSciences, Inc. pays -- of its earnings as a dividend. Theriva Biologics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios DTIL or TOVX?
Precision BioSciences, Inc. quarterly revenues are $13K, which are larger than Theriva Biologics, Inc. quarterly revenues of --. Precision BioSciences, Inc.'s net income of -$21.8M is lower than Theriva Biologics, Inc.'s net income of -$4.4M. Notably, Precision BioSciences, Inc.'s price-to-earnings ratio is 3.41x while Theriva Biologics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Precision BioSciences, Inc. is 72.20x versus 0.33x for Theriva Biologics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income DTILPrecision BioSciences, Inc.72.20x 3.41x $13K -$21.8M TOVXTheriva Biologics, Inc.0.33x -- -- -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 62x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Buy
54
SMX alert for Dec 5
SMX (Security Matters) Plc [SMX] is up 154.74% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
67
NUTX alert for Dec 5
Nutex Health, Inc. [NUTX] is up 18.9% over the past day.
